List of Contents

Vaccine Adjuvants Market Size, Share, and Trends 2024 to 2034

The global vaccine adjuvants market size is calculated at USD 1.73 billion in 2024, grew to USD 1.77 billion in 2025 and is predicted to hit around USD 2.18 billion by 2034, expanding at a CAGR of 2.33% between 2024 and 2034. The North America vaccine adjuvants market size is evaluated at USD 730 million in 2024 and is expected to grow at a CAGR of 2.38% during the forecast year.

  • Last Updated : December 2024
  • Report Code : 5349
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Vaccine Adjuvants Market 

5.1. COVID-19 Landscape: Vaccine Adjuvants Industry Impact

5.2. COVID-19  Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Vaccine Adjuvants Market, By Type

8.1. Vaccine Adjuvants Market Revenue and Volume, by Type, 2024-2034

8.1.1 Pathogen

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Adjuvant EMULSION

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Particulate

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Combination

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Vaccine Adjuvants Market, By Application

9.1. Vaccine Adjuvants Market Revenue and Volume, by Application, 2024-2034

9.1.1. Infectious DISEASE

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Cancer

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Vaccine Adjuvants Market, By Administrator

10.1. Vaccine Adjuvants Market Revenue and Volume, by Administrator, 2024-2034

10.1.1. Oral

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Intradermal

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Intranasal

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Intramuscular

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Vaccine Adjuvants Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by Administrator (2021-2034)

Chapter 12. Company Profiles

12.1. GlaxoSmithKline plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agenus

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Merck KGaA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. InvivoGen

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. CSL Limited

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Dynavax Technologies

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Croda International PLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. OZ Biosciences

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. SEPPIC

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. SPI Pharma

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global vaccine adjuvants market size is expected to grow from USD 1.73 billion in 2024 to USD 2.18 billion by 2034.

The vaccine adjuvants market is anticipated to grow at a CAGR of 2.33% between 2024 and 2034.

The major players operating in the vaccine adjuvants market are GlaxoSmithKline plc, Agenus, Merck KGaA, InvivoGen, CSL Limited, Dynavax Technologies, Croda International PLC, OZ Biosciences, SEPPIC, SPI Pharma, Phibro Animal Health Corporation, Sanofi, Aphios Corporation, Avanti Polar Lipids, Inc., Vertellus, and Others.

The driving factors of the vaccine adjuvants market is the it helps in the development of new vaccines for treating allergies, autoimmune diseases, and cancer.

North America region will lead the global vaccine adjuvants market during the forecast period 2024 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us